Business, energy, technology, markets and global industry news from Business News Today

behavioral health biotech

Pharma & Biotech

How Clearmind Medicine is positioning CMND-100 within the emerging non-hallucinogenic neuroplastogen market

Clearmind Medicine is advancing CMND-100 in Alcohol Use Disorder. Discover why the non-hallucinogenic neuroplastogen market is gaining attention.

Read More